Better Marijuana Stock: The Green Organic Dutchman vs. Innovative Industrial Properties

Which stock wins in a matchup between these two cannabis companies?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

This article was originally published on Fool.com

If you’re highly skeptical of the multibillion-dollar market caps of some of the most well-known marijuana stocks, there are other alternatives. Two that immediately jump to mind are The Green Organic Dutchman (NASDAQOTH:TGODF) and Innovative Industrial Properties (NYSE:IIPR). The former sports a market cap of a little less than $1 billion, while the latter claims a much smaller market cap of just shy of $400 million.

Innovative Industrial Properties has performed better so far in 2018 and with much lower volatility than The Green Organic Dutchman. But which of these two marijuana stocks is the better pick for investors now?

Marijuana growing in a greenhouse.

IMAGE SOURCE: GETTY IMAGES.

The case for The Green Organic Dutchman

You could argue that a big reason to buy The Green Organic Dutchman (TGOD) stock is that the company has already weathered its worst headwinds. Big partner Aurora Cannabis opted not to exercise an option to buy a bigger stake in TGOD last month. The company’s initial public offering (IPO) stock lock-up period expired last week without a big sell-off. And the huge sell-off of marijuana stocks as Canada’s legal recreational marijuana market opened appears to be over.

With these problems behind it, what are the positive factors to buy TGOD stock? For one thing, the company should be able to sell every gram of cannabis it can produce for a while to come. As many predicted, there were widespread product shortages in Canada as the country’s recreational marijuana market opened.

As of now, TGOD can’t produce any cannabis. However, the company expects to complete its Ontario and Quebec facilities in the first half of 2019. Together, these two facilities will enable TGOD to produce 156,000 kilograms annually. Add to that total another 14,000 kilograms from its Jamaica facility that should be ready to go by the end of this year.

One competitive advantage for TGOD is that it’s one of only two certified organic cannabis producers in Canada. This should give the company an edge with customers who prefer organic products. Also, organic products command premium prices.

TGOD is gearing up to compete internationally as well. The company owns nearly half of Jamaican cannabis company Epican, which has already opened one dispensary in the country, with plans to launch four more. TGOD wholly owns HemPoland, a Poland-based company that markets a well-known cannabidiol (CBD) brand in Europe. In addition, the company has a 50-50 joint venture in Mexico, which is projected to be one of the five biggest international medical marijuana markets outside of the U.S. and Canada.

The case for Innovative Industrial Properties

Why consider investing in Innovative Industrial Properties (IIP)? One reason is the company’s unique business model. IIP is a real estate investment trust (REIT) that provides capital to medical marijuana businesses. The company develops properties for use in producing medical cannabis and then leases the properties to tenants. IIP currently has nine tenants.

Another big plus for IIP is that it focuses on the huge U.S. market. IIP operates in seven states: Arizona, Maryland, Massachusetts, Michigan, Minnesota, New York, and Pennsylvania. Three of these states — Arizona, Massachusetts, and Michigan — should have marijuana markets topping $1 billion by 2022, according to Arcview Market Research and BDS Analytics. 

IIP also has plenty of opportunities to expand. Thirty U.S. states already allow the legal use of medical marijuana. And the medical marijuana markets in the states where the company already operates continue to grow.

Unlike many companies in the cannabis industry, IIP is profitable. It also has a strong balance sheet with no debt. The company’s leases are long term, with a weighted average lease length of 15 years and an average yield on invested capital of 15.7%. This should provide a steady stream of cash flow for IIP.

IIP also stands out from most marijuana stocks in that it pays a dividend. As an REIT, the company must return at least 90% of pretax income to shareholders in the form of dividend payments. IIP’s dividend currently yields an attractive 3.42%. 

Better buy

This decision is, in my view, practically a no-brainer. The Green Organic Dutchman has a market cap of nearly $1 billion with absolutely no revenue. Meanwhile, Innovative Industrial Partners claims healthy and growing revenue and profits. I think that IIP wins over TGOD.

It is important to note that marijuana remains illegal at the federal level in the U.S. This could present problems for IIP in the future. However, my take is that the likelihood of federal antimarijuana policies easing is greater than the likelihood of further restrictions. I think IIP could provide a good way for aggressive investors to profit from the growth in the U.S. cannabis industry.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool US recommends Innovative Industrial Properties. The Motley Fool has a disclosure policy.

 

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »